针刺联合中药治疗糖尿病前期的随机对照试验研究方案
本研究为72周随机对照试验(24周干预加48周随访),计划从广州医科大学附属第五医院招募80例糖尿病前期患者,随机分为治疗组(针刺加中药加健康教育)与对照组(仅健康教育),每组40例,主要评价空腹血糖、75克口服葡萄糖耐量试验后2小时血糖和糖化血红蛋白水平。
要点
- 研究纳入西医诊断为糖尿病前期的患者,随机分为针刺加中药加健康教育组与仅健康教育组,每组40例。
- 主要结局为空腹血糖、75克口服葡萄糖耐量试验后2小时血糖和糖化血红蛋白水平。
- 研究周期72周,其中干预24周、随访48周,并设安全性指标与质量控制。
核心结论
- 本研究旨在评价针刺联合中药治疗糖尿病前期患者的疗效与安全性。
研究设计与样本
- 本研究为随机对照试验,研究周期72周,其中干预24周、随访48周。
- 计划从中国广州医科大学附属第五医院招募80例西医诊断为糖尿病前期的参与者,随机分为治疗组(针刺加中药加健康教育)与对照组(仅健康教育),每组40例。
主要发现
- 终点指标包括糖尿病发病率和逆转率,主要结局为空腹血糖水平、75克口服葡萄糖耐量试验后2小时血糖水平和糖化血红蛋白水平。
- 次要结局包括体重指数和血液流变学(全血黏度切变率和血浆黏度)。
- 安全性指标包括肝功能(ALT、AST)、肾功能(BUN、Cr)及不良事件记录,不良事件包括腹泻、感冒、咽炎和睡眠障碍。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Type-2 diabetes has become a major disease and is known to seriously impair people's health worldwide. Prediabetes includes impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) and is the most critical period for preventing type-2 diabetes, as it can be identified and reversed. Studies in the past decade have indicated that acupuncture and Chinese herbal medicine may be beneficial for treating prediabetes. However, a randomized controlled trial (RCT) should be conducted to obtain more clinical evidence on this topic. METHODS/DESIGN: An RCT will be implemented in this study, using a72-week study period (24 weeks for the intervention and 48 weeks for follow-up). Participants will be recruited from the Fifth Affiliated Hospital of Guangzhou Medical University in China. Eighty participants will be randomized to the treatment group (acupuncture plus herbal medicine and health education) or the control group (health education only), 40 participants in each. People included in this study must have been diagnosed with prediabetes using Western medicine criteria. The endpoint indices include the incidence of diabetes mellitus and the reversion rate. The primary outcome is fasting plasma glucose (FPG) level, 2-h plasma glucose (2-hPG) level after a 75-g oral glucose tolerance test (OGTT), and glycosylated hemoglobin (HbA1c) level. Secondary outcomes include the following: Body Mass Index (BMI); hemorheology, including shear rates of whole-blood viscosity and plasma viscosity. Safety indices include hepatic (ALT, AST) and renal function (BUN, Cr) and records of adverse events, including diarrhoea, colds, pharyngitis, and sleep disorders. Quality control will be implemented, including quality control of the laboratory, researchers, participants, investigational drugs, data and documents, occurrence of bias, supervision, among others, according to uniform standard operating procedures (SOPs) which have been established by the Good Clinical Practice (GCP) office of the Fifth Affiliated Hospital of Guangzhou Medical University. DISCUSSION: The aim of this study is to evaluate the efficacy and safety of acupuncture paired with herbal medicine for the treatment of patients with prediabetes. TRIAL REGISTRATION: Chinese clinical trials register ChiCTR-INR-16008891 . Registered on 23 July 2016.
引用
- Li X, Liu H, Feng H, et al. Acupuncture paired with herbal medicine for prediabetes: study protocol for a randomized controlled trial. Trials. 2017. PMID: 28659162. doi:10.1186/s13063-017-2014-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。